Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes. - Grundy,S.M.; Vega,G.L.; McGovern,M.E.; Tulloch,B.R.; Kendall,D.M.; Fitz-Patrick,D.; Ganda,O.P.; Rosenson,R.S.; Buse,J.B.; Robertson,D.D.; Sheehan,J.P. (Arch Intern Med, 2002)